Vigil Health Solutions Reports Profitable Third Quarter
VICTORIA, BRITISH COLUMBIA--(Marketwired - Feb 6, 2014) - Vigil
Health Solutions Inc. ("Vigil") (TSX-VENTURE:VGL) announces the
results of operations for the quarter ending December 31, 2013.
Business Highlights
- Revenue grew 19% to $1.30 million up from $1.10 million in the
three-month period ended December 31, 2012
- Bookings for the quarter were $1.15 million up 5% compared to
$1.09 million in the three-month period ended December 31,
2012
- Increased backlog to approximately $3.15 million compared to
approximately $2.76 million in the three-month period ended
December 31, 2012
- Net Income of $20 thousand compared to $132 thousand in the
three month period ended December 31, 2012
"We continue to see sales and revenue growth and we are focusing
on new product development while controlling operating costs to
maintain and improve on sales and profitability," stated Troy
Griffiths, President and CEO of Vigil Health Solutions Inc.
Financial Results
Revenue for the three-months ended December 31, 2013 was $1.30
million compared to $1.10 million in the three-month period ended
December 31, 2012, an increase of 19%. Project revenue made up 69%
of total revenue; the remaining revenue came from follow on sales
to existing customers. These sales include service and maintenance
billings and replacement products including wireless devices and
communication equipment.
Bookings for the quarter were $1.15 million up 5% compared to
$1.09 million in the three-month period ended December 31,
2012.
At December 31, 2013 Vigil had a backlog of approximately $3.15
million (including $1.65 million in deposits and progress billings,
recorded as deferred revenue on the balance sheet) a 14% increase
compared to approximately $2.76 million (including $611 thousand in
deposits and progress billings, recorded as deferred revenue on the
balance sheet) at December 31, 2012. At December 31, 2013, Vigil's
backlog included 37 projects at varying stages of installation and
progress billing with an average project size of $85 thousand.
Projects can include individual buildings or floors of multiple
phase campus construction.
The gross margin percentage for the three months ended December
31, 2013 was 45% compared to 50% for the three months ended
December 31, 2012. Gross margin was within management's usual
expectations of margins of between 42% and 47%. Margins have been
higher in previous quarters due to a large number of one off sales,
which usually have better margins due to the lower labour
component.
Expenditures for the three months ended December 31, 2013 were
$568 thousand, up 34% from $424 thousand for the period ended
December 31, 2012. The increase is primarily due to increased
compensation costs reflecting higher staffing levels. Staffing is
now back to normal levels similar to those seen prior to the
recession.
Net income for the three month period ended December 31, 2013
was $20 thousand, or $0.001 per share compared to income of $132
thousand, or $0.010 per share for the previous year. The decline in
profitability reflects the small decrease in gross profit and
increasing operating costs as staffing levels rise, inline with the
increase in business activity and new product development.
Detailed financial statements along with Management Discussion
and Analysis have been filed with SEDAR (www.sedar.com).
Financial information will be mailed to entitled security
holders on February 21, 2013. Or, upon notice to the Company,
entitled security holders may request a copy of financials in
advance.
Summary Financial Information
|
Three months ended |
Nine months ended |
|
December 31, 2013 |
December 31, 2012 |
December 31, 2013 |
December 31, 2012 |
|
|
|
|
|
Revenue |
$ |
1,302,766 |
|
1,096,167 |
3,506,869 |
2,595,829 |
|
Cost of sales |
|
712,687 |
|
546,081 |
1,856,694 |
1,311,835 |
|
|
|
590,079 |
|
550,086 |
1,650,175 |
1,283,994 |
|
|
|
|
|
|
|
|
|
Expenses |
|
568,422 |
|
424,482 |
1,609,079 |
1,180,457 |
|
|
|
|
|
|
|
|
|
Income (loss) before the following items |
|
21,657 |
|
125,604 |
41,096 |
103,537 |
|
|
|
|
|
|
|
|
|
Other
income (expense) |
|
(1,232 |
) |
6,099 |
21,375 |
(967 |
) |
|
|
|
|
|
|
|
|
Income / (loss) for the period |
$ |
20,425 |
|
131,703 |
62,471 |
102,570 |
|
Non-IFRS Measure
For the three months ended December 31, 2013, we are disclosing
Adjusted EBITDA, a non-IFRS financial measure, as a supplementary
indicator of operating performance. We define Adjusted EBITDA as
net income before, interest, income taxes, amortization, stock
based compensation and currency gains or losses including
derivative foreign exchange differences. We are presenting the
non-IFRS financial measure in our filings because we use it
internally to make strategic decisions, forecast future results and
to evaluate our performance and because we believe that our current
and potential investors and analysts use the measure to assess
current and future operating results and to make investment
decisions. It is a non-IFRS measure, may not be comparable to other
companies and it is not intended as a substitute for IFRS
measures.
|
|
Three months ended |
|
Nine months ended |
|
December 31, 2013 |
December 31, 2012 |
December 31, 2013 |
December 31, 2012 |
|
|
|
|
|
Income / (loss) for the period |
$ |
20,425 |
|
131,703 |
|
62,471 |
|
102,570 |
|
|
|
|
|
|
|
|
|
|
|
Add / (deduct) |
|
|
|
|
|
|
|
|
|
|
Foreign exchange |
|
(2,746 |
) |
(9,970 |
) |
(22,219 |
) |
(16,731 |
) |
|
Derivative exchange |
|
4470 |
|
79 |
|
481 |
|
5,721 |
|
|
Interest |
|
(492 |
) |
3,792 |
|
363 |
|
11,977 |
|
|
Stock
based compensation |
|
17,013 |
|
13,458 |
|
51,635 |
|
26,812 |
|
|
Amortization |
|
4,281 |
|
3,814 |
|
11,947 |
|
12,043 |
|
|
|
|
|
|
|
|
|
|
|
|
|
22,526 |
|
11,173 |
|
42,207 |
|
39,822 |
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
$ |
42,951 |
|
142,876 |
|
104,678 |
|
142,393 |
|
About Vigil Health Solutions Inc.
Vigil offers a proprietary technology platform combining
software and hardware to provide comprehensive solutions to the
expanding seniors' housing market. Vigil has established a growing
presence in North America and an international reputation for being
on the leading edge of systems design and integration. Vigil's
objective is to offer solutions for the full continuum of care.
Vigil's product range includes the innovative wireless Vitality
Care System™ featuring discreet 'mini pendants', a nurse call
system, mobile fall, incontinence monitoring, resident check and
the award-winning Vigil Dementia System.
Certain statements contained in this news release that are
not based on historical facts may constitute forward-looking
statements or forward-looking information within the meaning of
applicable securities laws ("forward-looking statements"). These
forward-looking statements are not promises or guarantees of future
performance but are only predictions that relate to future events,
conditions or circumstances or our future results, performance,
achievements or developments and are subject to substantial known
and unknown risks, assumptions, uncertainties and other factors
that could cause our actual results, performance, achievements or
developments in our business or in our industry to differ
materially from those expressed, anticipated or implied by such
forward-looking statements.
Forward-looking statements include all financial guidance,
disclosure regarding possible events, conditions, circumstances or
results of operations that are based on assumptions about future
economic conditions, courses of action and other future events. We
caution you not to place undue reliance upon any such
forward-looking statements, which speak only as of the date they
are made. These forward-looking statements appear in a number of
different places in this presentation and can be identified by
words such as "may", "estimates", "projects", "expects", "intends",
"believes", "plans", "anticipates", or their negatives or other
comparable words. Forward-looking statements include statements
regarding the outlook for our future operations, plans and timing
for the introduction or enhancement of our services and products,
statements concerning strategies or developments, statements about
future market conditions, supply conditions, end customer demand
conditions, channel inventory and sell through, revenue, gross
margin, operating expenses, profits, forecasts of future costs and
expenditures, the outcome of legal proceedings, and other
expectations, intentions and plans that are not historical
fact.
The risk factors and uncertainties that may affect our
actual results, performance, achievements or developments are many
and include, amongst others, our ability to develop our sales force
and generate revenue, the length of the sales cycle, management of
the Company's growth, ability to recruit and retain staff,
fluctuations in demand for current and future products, our ability
to develop, manufacture, supply and market existing and new
products that meet the needs of customers, volatility in the
exchange rate, ability to secure financing, ability to secure
product liability insurance, the continuous commitment of our
customers, increased competition, changes in regulation and
reliance on third party suppliers. These risk factors and others
are discussed in the Risks and Uncertainties section of our
"Management Discussion and Analysis" segment of our fiscal 2013
Annual Report. Many of these factors and uncertainties are beyond
the control of the Company. Consequently, all forward-looking
statements in this news release are qualified by this cautionary
statement and there can be no assurance that actual results,
performance, achievements or developments anticipated by the
Company will be realized.
Forward-looking statements are based on management's current
plans, estimates, projections, beliefs and opinions and, except as
required by law, the Company does not undertake any obligation to
update forward-looking statements should the assumptions related to
these plans, estimates, projections, beliefs and opinions
change.
The TSX Venture Exchange has not reviewed and does not
accept responsibility for the adequacy or accuracy of this
release.
Vigil Health Solutions Inc.Troy GriffithsPresident and CEO(250)
383-6900(250) 383-6999information@vigil.comwww.vigil.com
Vigil Health Solutions (TSXV:VGL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Vigil Health Solutions (TSXV:VGL)
Historical Stock Chart
From Dec 2023 to Dec 2024